Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
QUICKFIRE
Janssen Research & Development, LLC and BARDA will collaborate on a global challenge for reimagined, transformative respiratory protection.
Traditional respiratory protective devices used to protect against inhalation of harmful infectious agents were designed for use in occupational settings,
to guard against inhalation of dangerous particulates.
Disposable versions, such as N95 respirators, are only available for adults, must be fit-tested to ensure proper functioning, and can be uncomfortable to wear.
In an outbreak of a novel or newly emerging respiratory disease, respiratory protection may be the only countermeasure available to protect health care workers and the general public.
Janssen Research & Development, LLC will partner with JLABS, which exists to foster innovation in health care products and executes QuickFire Challenges for health care innovation.
There is no direct equivalent of the QuickFire Challenge services for innovation specific to health care as is provided by JLABS.
Its unique service will directly benefit BARDA's mission to make available medical countermeasures to address health security threats.
Supporting innovation is an authority provided to BARDA under the Public Health Service Act and partnering with a company providing a diverse array of products and leveraging its expertise and infrastructure has the potential to provide solutions to the challenges in developing new respiratory devices.
Reimagined, innovative respiratory protection would contribute directly to ASPR's mission to save lives and protect Americans against 21st Century health security threats.
Respiratory protection is often the first line of defense, and a radically improved approach to protect both health care workers and the general public, including children, would truly improve our ability to respond to public health emergencies.
By generating interest and focusing innovation efforts on reimagining respiratory protection, BARDA's goal for the QuickFire Challenge is for the resulting innovative approaches to be eligible for continued testing and development and eventual regulatory approval, so that these revolutionary products can be widely available and used.
Traditional respiratory protective devices used to protect against inhalation of harmful infectious agents were designed for use in occupational settings,
to guard against inhalation of dangerous particulates.
Disposable versions, such as N95 respirators, are only available for adults, must be fit-tested to ensure proper functioning, and can be uncomfortable to wear.
In an outbreak of a novel or newly emerging respiratory disease, respiratory protection may be the only countermeasure available to protect health care workers and the general public.
Janssen Research & Development, LLC will partner with JLABS, which exists to foster innovation in health care products and executes QuickFire Challenges for health care innovation.
There is no direct equivalent of the QuickFire Challenge services for innovation specific to health care as is provided by JLABS.
Its unique service will directly benefit BARDA's mission to make available medical countermeasures to address health security threats.
Supporting innovation is an authority provided to BARDA under the Public Health Service Act and partnering with a company providing a diverse array of products and leveraging its expertise and infrastructure has the potential to provide solutions to the challenges in developing new respiratory devices.
Reimagined, innovative respiratory protection would contribute directly to ASPR's mission to save lives and protect Americans against 21st Century health security threats.
Respiratory protection is often the first line of defense, and a radically improved approach to protect both health care workers and the general public, including children, would truly improve our ability to respond to public health emergencies.
By generating interest and focusing innovation efforts on reimagining respiratory protection, BARDA's goal for the QuickFire Challenge is for the resulting innovative approaches to be eligible for continued testing and development and eventual regulatory approval, so that these revolutionary products can be widely available and used.
Related Programs
Biomedical Advanced Research and Development Authority (BARDA), Biodefense Medical Countermeasure De
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: Assistant Secretary for Preparedness and Response
Estimated Funding: $100,000
Office: Assistant Secretary for Preparedness and Response
Estimated Funding: $100,000
Who's Eligible
Obtain Full Opportunity Text:
QUICKFIRE
Additional Information of Eligibility:
Eligible Applicants: All proposals must originate from a U. S. college or university designated and listed by the Department of Education as a Postsecondary Minority Institution, Historically Black College or University, Hispanic-Serving Institution or Tribal College or University.
See http://www.ed.gov/about/offices/list/ocr/edlite-minorityinst.html.
Institutions qualifying for this funding opportunity must offer graduate degrees in engineering, computer science, technology, mathematics, or science disciplines.
Additional Information on Eligibility: Only one proposal may be submitted per institution or university system.
Institutions with current Group 4 University Research Centers are not eligible to propose for this solicitation.
Full Opportunity Web Address:
https://www.grantsolutions.gov/gs/preaward/previewPublicAnnouncement.do?id=62731
Contact:
Agency Email Description:
Grantsolutions Help Desk
Agency Email:
Date Posted:
2018-09-24
Application Due Date:
Archive Date:
2018-10-25
Social Entrepreneurship
Spotlight
Why People Buy from Social Enterprises?
The Guardian has compiled a list of responses to its latest open thread, and has announced the winner of the social enterprise gift hamper packed with presents.
Learn How to Identify and Avoid Grant Scams
